CHIEF FINANCIAL OFFICER · Harmony Biosciences Holdings, Inc. · Common Stock
Side
SELL
Value
$139K
Shares
3,746
Price
$37.15
Executed
Jan 26, 2026
Disclosed
Jan 28, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 26 executedJan 28, 2026 disclosed
HRMY · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kapadia Sandip filed this Form 4 reporting a open-market sale of HRMY on Jan 26, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF FINANCIAL OFFICER
Kapadia Sandipcik:0001677141
Issuer
Harmony Biosciences Holdings, Inc.cik:0001802665
Revision history · 0
No field has changed since this record was first ingested.
